Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Am J Pathol ; 158(2): 627-37, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11159199

RESUMO

Rejection of renal and cardiac xenografts is initiated when natural antibodies of the recipient bind to donor endothelium, activating complement on the surface of endothelial cells. Pulmonary xenotransplants, however, reveal less evidence of antibody binding and complement activation and, in contrast to other xenografts, fare worse when the complement of the graft recipient is depleted. Accordingly, we asked whether distinct immunochemical reactions might occur after xenotransplantation of the lung and what implications such reactions might have for pulmonary pathophysiology. Analysis of serum from baboons after transplantation with porcine lungs revealed complexes containing baboon IgM and porcine von Willebrand factor. The baboon IgM in these complexes was specific for Galalpha1-3Gal. Immune complexes were also seen, albeit to a lesser extent, in the serum of kidney and heart xenotransplant recipients. Deposits of porcine von Willebrand factor and baboon C3 were detected in livers and spleens of transplanted baboons. These results indicate pulmonary xenotransplantation eventuates in formation of immune complexes and in the deposition of those complexes at distant sites. Immune complex formation could explain the peculiar fate of xenoreactive antibodies after pulmonary xenotransplantation and might contribute to the pathophysiology of the lung and systemic changes not previously considered a complication of xenotransplantation.


Assuntos
Complexo Antígeno-Anticorpo/imunologia , Transplante Heterólogo/imunologia , Animais , Anticorpos Heterófilos/metabolismo , Complexo Antígeno-Anticorpo/sangue , Antígenos de Superfície/sangue , Antígenos de Superfície/imunologia , Western Blotting , Células Cultivadas , Endotélio Vascular/imunologia , Endotélio Vascular/fisiopatologia , Rejeição de Enxerto/imunologia , Rejeição de Enxerto/fisiopatologia , Transplante de Coração-Pulmão/imunologia , Rim/imunologia , Rim/metabolismo , Transplante de Rim/imunologia , Fígado/imunologia , Pulmão/imunologia , Pulmão/metabolismo , Pulmão/ultraestrutura , Miocárdio/imunologia , Miocárdio/metabolismo , Papio , Ligação Proteica , Baço/imunologia , Suínos , Fatores de Tempo , Imunologia de Transplantes
7.
Glycobiology ; 10(5): 467-75, 2000 May.
Artigo em Inglês | MEDLINE | ID: mdl-10764835

RESUMO

Heparan sulfate proteoglycans play a pivotal role in tissue function, development, inflammation, and immunity. We have identified a novel cDNA encoding human heparanase, an enzyme thought to cleave heparan sulfate in physiology and disease, and have located the HEP gene on human chromosome 4q21. Monoclonal antibodies against human heparanase located the enzyme along invasive extravillous trophoblasts of human placenta and along endothelial cells in organ xenografts targeted by hyperacute rejection, both sites of heparan sulfate digestion. Heparanase deposition was evident in arterial walls in normal tissues; however, vascular heparan sulfate cleavage was coincident with heparanase enzyme during inflammatory episodes. These findings suggest that heparanase elaboration and control of catalytic activity may contribute to the development and pathogenesis of vascular disease and suggest that heparanase intervention might be a useful therapeutic target.


Assuntos
Expressão Gênica , Glucuronidase , Glicosídeo Hidrolases/genética , Trofoblastos/enzimologia , Doenças Vasculares/enzimologia , Sequência de Aminoácidos , Animais , Anticorpos Monoclonais , Linhagem Celular , Cromossomos Humanos Par 4 , DNA Complementar/análise , Endotélio Vascular/enzimologia , Glicosídeo Hidrolases/análise , Glicosídeo Hidrolases/imunologia , Rejeição de Enxerto/enzimologia , Heparitina Sulfato/metabolismo , Humanos , Inflamação/enzimologia , Dados de Sequência Molecular , Fragmentos de Peptídeos/imunologia , Suínos
8.
Transplantation ; 69(4): 475-82, 2000 Feb 27.
Artigo em Inglês | MEDLINE | ID: mdl-10708098

RESUMO

BACKGROUND: Acute vascular rejection destroys vascularized xenografts over a period of hours to days and is now considered the major hurdle to the clinical application of xenotransplantation. The hallmark of acute vascular rejection is diffuse intravascular coagulation; however, the pathogenesis of coagulation is a matter of controversy. One line of evidence points to activated endothelial cells and another to activated inflammatory cells as a source of tissue factor and thus as a primary cause of this lesion. The distinction between the two mechanisms inducing coagulation in the xenograft provides an opportunity for specific intervention. METHODS: To explore these mechanisms, we studied the expression of tissue factor mRNA by in situ reverse transcriptase-polymerase chain reaction in relation to the histopathologic manifestations of acute vascular rejection in guinea pig hearts transplanted into rats treated by cobra venom factor to avoid the hyperacute rejection. RESULTS: Three hours after transplantation and before the deposition of fibrin, tissue factor mRNA was expressed in the endothelial cells lining small and medium blood vessels and in smooth muscle cells of guinea pig cardiac xenografts. Sixteen hours after transplantation, while rat tissue factor mRNA was expressed only in occasional infiltrating cells, cardiac xenografts showed prominent deposits of fibrin in small vessels. Maximum expression of tissue factor on rat infiltrating cells was observed 48 hr after transplantation. CONCLUSIONS: These results suggest that in acute vascular rejection, coagulation is initiated on the donor vascular system, while the procoagulant characteristics of infiltrating cells may reflect a response to tissue injury rather than a cause.


Assuntos
Transplante de Coração/imunologia , Tromboplastina/genética , Transplante Heterólogo , Doença Aguda , Animais , Vasos Coronários/transplante , Endotélio Vascular/citologia , Endotélio Vascular/imunologia , Rejeição de Enxerto/etiologia , Cobaias , Transplante de Coração/fisiologia , Antígenos Comuns de Leucócito/análise , Leucócitos/imunologia , Masculino , RNA Mensageiro/metabolismo , Ratos , Ratos Endogâmicos Lew , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Fatores de Tempo , Transplante Heterólogo/patologia , Resultado do Tratamento
9.
Diagn Mol Pathol ; 7(2): 76-84, 1998 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-9785005

RESUMO

In situ hybridization (ISH) detection of low copy DNA and RNA sequences using nonisotopic probes has been difficult in the past because of a lack of sensitivity. Several techniques, such as ISH with radioisotopic-labeled probes, in situ polymerase chain reaction, in situ reverse transcription polymerase chain reaction, self-sustained sequence replication, and chemiluminescence, have allowed increased sensitivity but have required specialized and often expensive equipment, lengthy protocols, and in the case of radioactive probes, there has been an associated increased health risk. Catalyzed reporter deposition (CARD) combined with ISH (CARD-ISH) increases the signal-generating potential of labeled hybridized probes and allows the detection of low copy sequences of nucleic acids in formalin-fixed, paraffin-embedded tissue sections. To determine the sensitivity of CARD-ISH to detect nucleic acids in routinely processed specimens, we analyzed the detection of HPV 16 and 18 infection in formalin-fixed, paraffin-embedded sections of cultured cell lines, including CaSki cells with 400-600 copies of HPV 16, HeLa 229 cells with 10-50 copies of HPV 18, and SiHa cells with 1-2 copies of HPV 16 using a conventional ISH method and by CARD-ISH. In addition, 20 cases of clinical specimens previously analyzed for HPV 6, 11, 16, 18, 31, 33, and 51 with the Enzo PathoGene kit (Enzo Diagnostics, Inc., Farmingdale, NY, U.S.A.) were reexamined with the CARD-ISH method. The CARD-ISH system detected one to two copies of HPV 16 in the SiHa cells whereas the conventional ISH method did not. Both methods detected HPV 16 and 18 in CaSki and HeLa 229 cells, respectively. Three clinical cases that were previously negative and two weakly positive cases of HPV infection were all strongly positive with the CARD-ISH system, a 25% increase in the detection of positive cases by CARD-ISH. We also showed for the first time that a cocktail of six biotinylated oligonucleotide probes was capable of detecting one to two copies of HPV 16 in SiHa cells. These results show that the CARD-ISH method increases the sensitivity of nonisotopic ISH to the level of detecting one to two copies of HPV DNA in formalin-fixed, paraffin-embedded tissue sections using biotinylated cDNA or oligonucleotide probes.


Assuntos
Biotina/análogos & derivados , Sondas de DNA de HPV , DNA Viral/isolamento & purificação , Hibridização In Situ/métodos , Papillomaviridae/classificação , Infecções por Papillomavirus/virologia , Infecções Tumorais por Vírus/virologia , Tiramina/análogos & derivados , 3,3'-Diaminobenzidina , Biotina/análise , Biotinilação , Fluoresceína , Formaldeído , Células HeLa/virologia , Peroxidase do Rábano Silvestre , Humanos , Papillomaviridae/genética , Papillomaviridae/isolamento & purificação , Inclusão em Parafina , Reação em Cadeia da Polimerase , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Estreptavidina , Fixação de Tecidos , Células Tumorais Cultivadas/virologia , Tiramina/análise
10.
Hum Pathol ; 29(3): 280-8, 1998 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-9496832

RESUMO

Placental site trophoblastic tumor (PSTT) consists of a neoplastic proliferation of intermediate or extravillous trophoblast (also known as X cells). Pregnancy-associated major basic protein (pMBP) is a marker for placental intermediate trophoblast. We compared the distribution of pMBP and human placental lactogen (hPL) in 24 PSTT and 3 exaggerated placental site (EPS) specimens using two distinct immunohistologic methods. Statistical analyses were used to compare staining intensities in metastatic and nonmetastatic lesions. By immunofluorescence, 77% of the PSTT specimens and 100% of the EPS specimens stained with antibodies to pMBP, and the pMBP was localized in intermediate trophoblast and surrounding extracellular areas. By immunohistochemistry, 78% of the PSTT specimens and 100% of the EPS specimens stained for pMBP with a pattern comparable with that of immunofluorescence. Likewise, by immunohistochemistry, hPL stained 96% of the PSTT specimens and 100% of the EPS specimens. Immunohistochemical staining intensities for pMBP and hPL correlated (r2 = +.24; P = .013), but hPL staining was mainly confined to intermediate trophoblast and was more intense. Anti-pMBP tended to stain metastatic PSTT weakly. Thus, pMBP is a useful marker for intermediate trophoblast tumors and could help distinguish these from other forms of trophoblastic disease.


Assuntos
Biomarcadores Tumorais/metabolismo , Lactogênio Placentário/metabolismo , Complicações Neoplásicas na Gravidez/metabolismo , Proteína Plasmática A Associada à Gravidez/metabolismo , Tumor Trofoblástico de Localização Placentária/metabolismo , Neoplasias Uterinas/metabolismo , Adulto , Feminino , Técnica Indireta de Fluorescência para Anticorpo , Humanos , Técnicas Imunoenzimáticas , Pessoa de Meia-Idade , Gravidez , Complicações Neoplásicas na Gravidez/patologia , Tumor Trofoblástico de Localização Placentária/patologia , Tumor Trofoblástico de Localização Placentária/secundário , Neoplasias Uterinas/patologia
11.
Surgery ; 118(6): 957-65; discussion 965-6, 1995 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-7491540

RESUMO

BACKGROUND: The existence of primary gastrinomas in lymph nodes continues to be controversial, because distinction from metastases from occult or regressed primary tumors may be difficult to exclude with certainty. If primary nodal gastrinomas do indeed occur, precursor neuroendocrine cells should be identifiable within lymph nodes. In a effort to detect these cells we undertook an immunohistochemical survey of regional pancreatic lymph nodes by using antibody against chromogranin, a highly specific marker for mature neuroendocrine cells. METHODS: We retrospectively identified consecutive cases from five surgeons in which Whipple resections had been performed for nonendocrine pathologic conditions. All formalin-fixed, paraffin-embedded lymph nodes were identified from these 106 cases, excluding lymph nodes with metastases. Immunoperoxidase staining with monoclonal antibody against chromogranin A was performed on single tissue sections. All slides were reviewed by a single pathologist; chromogranin-positive cells were identified and, when possible, further evaluated immunohistochemically with additional neuroendocrine markers, including sequential synaptophysin staining. RESULTS: A total of 1026 lymph nodes were available for review. Although well-formed intranodal chromogranin-positive nests were not identified, six nodes from three patients contained 13 strongly chromogranin-positive cells representing putative neuroendocrine cells. Mast cells showed weak nonspecific staining with chromogranin but were morphologically distinct. Perinodal adipose tissue contained a single paraganglion and several small neuroendocrine clusters. CONCLUSIONS: Putative neuroendocrine cells are rarely (less than 1%) found in regional pancreatic lymph nodes. Although these may be embryonic rests and might represent precursors of primary nodal gastrinomas, specific hormones have yet to be identified in these cells. Although these data provide support for the concept of primary nodal gastrinomas, this remains a diagnosis of exclusion.


Assuntos
Gastrinoma/patologia , Técnicas Imunoenzimáticas , Linfonodos/patologia , Sistemas Neurossecretores/patologia , Neoplasias Pancreáticas/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Cromogranina A , Cromograninas/análise , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Sinaptofisina/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...